New York, NY · Founded 2016 · Privately Held (backing)
Developer of a synthetic virology platform designed to engineer oncolytic viral therapies for cancer treatment. Humane Genomics is based in New York, NY and was founded in 2016. Its last reported valuation was $17 million in Feb 2025. It has raised $8.1 million.
Last reported valuation
$17.0M
Oct 2026
Priced at
—
Total raised
$8.1M
Last round
—
How much has Humane Genomics raised?
$8.1Macross 0 recorded rounds
Free account
More of Humane Genomics with a free account
·The complete investor list: 17 names
·Watch Humane Genomics: the Monday email on marks, rounds and moves